✦ LIBER ✦

[653] INTELLIGENCE PLATFORM FOR CHRONIC HEPATITIS C (CHC): MODEL OF THE DISEASE AND PREDICTION OF CLINICAL OUTCOME

✍ Scribed by M. Trapero-Marugan; M. Marin; X. Salcedo-Mora; T.M. del Rio; J.P. Pivel; R. Moreno-Otero

Book ID: 117375744
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 151 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)62251-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analytic modeling to predict the outcome

Analytic modeling to predict the outcome of chronic hepatitis C infection: A useful clinical tool or an unfair representation of natural history?

✍ Nizar N. Zein 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Objective: Chronic infection with hepatitis C may lead to the development of cirrhosis, liver failure, and hepatocellular carcinoma. However, not all patients progress to these endpoints. Ideally, clinicians could improve their capability of stratifying the risk and the time frame within which their

T1972 Clinical Presentation of Chronic H

T1972 Clinical Presentation of Chronic Hepatitis B (CHB) and C (CHC) and the Risks for Cirrhosis and/or Hepatic Decompensation (HD) and Hepatocellular Carcinoma (HCC) in Asian Americans

✍ Abbasi, Ali; Pan, Calvin; Xia, Victor W.; Hu, Ke-Qin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Comparison of the model for end-stage li

Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis

✍ C.-Y. Hsu; H.-C. Lin; Y.-H. Huang; C.-W. Su; F.-Y. Lee; T.-I. Huo; P.-C. Lee; J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Impact of disease severity on outcome of

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial

✍ Gregory T. Everson; John C. Hoefs; Leonard B. Seeff; Herbert L. Bonkovsky; Deepa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 1 views

In patients with chronic hepatitis C, advanced fibrosis and cirrhosis are associated with lower rates of sustained virologic response (SVR) to interferon (IFN)-based therapy. In this study, we assessed virologic response to retreatment with peginterferon alfa-2a and ribavirin (RBV), as a function of

A predictive model for the development o

A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C

✍ Peter A.L Bonis; Myron J Tong; Lawrence M Blatt; Andrew Conrad; John L Griffith 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Assessment of health-related quality of

Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

✍ Matsushita, Hiroshi; Ikeda, Fusao; Iwasaki, Yoshiaki; Seki, Hiroyuki; Nanba, Shi 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB